Novartis AG Operating Expenses 2011-2026 | NVS

Annual Operating Expenses Novartis AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	24.6 B	25.2 B	26.6 B	24.3 B	23.6 B	24 B	25.2 B	28.3 B	27.3 B	29.4 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
29.4 B	23.6 B	25.9 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Heron Therapeutics HRTX	281 M	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 19.23	-1.38 %	$ 899 M	USA
Altimmune ALT	94.5 M	$ 3.44	2.99 %	$ 303 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	338 M	$ 218.06	-1.72 %	$ 5 B	Danmark
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Incyte Corporation INCY	1.62 B	$ 90.45	-0.36 %	$ 17.7 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Inovio Pharmaceuticals INO	145 M	$ 1.61	1.9 %	$ 35.7 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Inventiva S.A. IVA	36.2 M	$ 6.08	5.19 %	$ 138 M	France
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	242 M	$ 12.84	0.78 %	$ 774 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
KalVista Pharmaceuticals KALV	188 M	$ 16.6	-2.35 %	$ 824 M	Britain
Kamada Ltd. KMDA	69 K	$ 8.2	-0.61 %	$ 260 M	Israel
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Karyopharm Therapeutics KPTI	265 M	$ 6.66	-12.71 %	$ 812 K	USA
Keros Therapeutics KROS	176 M	$ 11.24	2.55 %	$ 418 M	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Longeveron LGVN	24.1 M	$ 0.95	-2.71 %	$ 16.7 B	USA
Denali Therapeutics DNLI	502 M	$ 21.09	4.56 %	$ 3.47 B	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.42	4.25 %	$ 734 M	Canada
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA